Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

● The company has a good ESG score relative to its sector, according to Refinitiv.


Strengths

● With a P/E ratio at 11.99 for the current year and 10.16 for next year, earnings multiples are highly attractive compared with competitors.

● The stock, which is currently worth 2023 to 0.45 times its sales, is clearly overvalued in comparison with peers.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● The company is one of the best yield companies with high dividend expectations.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● Considering the small differences between the analysts' various estimates, the group's business visibility is good.

● The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● According to forecast, a sluggish sales growth is expected for the next fiscal years.

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.

● The company sustains low margins.

● For the last few months, analysts have been revising downwards their earnings forecast.

● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.

● Over the past twelve months, analysts' opinions have been revised negatively.